Literature DB >> 2200492

Oral nimodipine and cerebral ischaemia following subarachnoid haemorrhage.

J D Pickard1, G D Murray, R Illingworth, M D Shaw, G M Teasdale, P M Foy, P R Humphrey, D A Lang, R Nelson, P Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2200492

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN： 0007-0947


× No keyword cloud information.
  4 in total

1.  Challenges in collecting pharmacokinetic and pharmacodynamic information in an intensive care setting: PK/PD modelling of clazosentan in patients with aneurysmal subarachnoid haemorrhage.

Authors:  Jochen Zisowsky; Eliane Fuseau; Shirin Bruderer; Andreas Krause; Jasper Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  2014-01-24       Impact factor: 2.953

2.  Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage.

Authors:  F Porchet; R Chioléro; N de Tribolet
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 3.  Calcium antagonists for aneurysmal subarachnoid haemorrhage.

Authors:  S M Dorhout Mees; G J E Rinkel; V L Feigin; A Algra; W M van den Bergh; M Vermeulen; J van Gijn
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 4.  Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives.

Authors:  Giovanni Grasso; Concetta Alafaci; R Loch Macdonald
Journal:  Surg Neurol Int       Date:  2017-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.